Andrey A Zamyatnin Jr
Overview
Explore the profile of Andrey A Zamyatnin Jr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
120
Citations
1474
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Persano F, Parodi A, Pallaeva T, Kolesova E, Zamyatnin Jr A, Pokrovsky V, et al.
Cancers (Basel)
. 2025 Mar;
17(5).
PMID: 40075706
The implementation of novel analytic methodologies in cancer and biomedical research has enabled the quantification of parameters that were previously disregarded only a few decades ago. A notable example of...
2.
Kostyusheva A, Romano E, Yan N, Lopus M, Zamyatnin Jr A, Parodi A
Adv Drug Deliv Rev
. 2025 Jan;
218:115522.
PMID: 39855273
Exosomes have emerged as promising tools for targeted drug delivery in biomedical applications and medicine. This review delves into the scientific advancements, challenges, and future prospects specifically associated with these...
3.
Kostyusheva A, Brezgin S, Ponomareva N, Frolova A, Lunin A, Bayurova E, et al.
Mol Ther
. 2024 Nov;
33(1):168-183.
PMID: 39511888
The demand for RNA-based therapeutics is increasing globally. However, their use is hampered by the lack of safe and effective delivery vehicles. Here, we developed technologies for highly efficient delivery...
4.
Tikhonov A, Kachanov A, Yudaeva A, Danilik O, Ponomareva N, Karandashov I, et al.
Pharmaceutics
. 2024 Oct;
16(10).
PMID: 39458635
Biomimetic nanoparticles (BMNPs) are innovative nanovehicles that replicate the properties of naturally occurring extracellular vesicles, facilitating highly efficient drug delivery across biological barriers to target organs and tissues while ensuring...
5.
Brezgin S, Danilik O, Yudaeva A, Kachanov A, Kostyusheva A, Karandashov I, et al.
Int J Mol Sci
. 2024 Oct;
25(19).
PMID: 39408730
Extracellular vesicles (EVs) are natural carriers of biomolecules that play a crucial role in cell-to-cell communication and tissue homeostasis under normal and pathological conditions, including inflammatory diseases and cancer. Since...
6.
Brezgin S, Frolova A, Bayurova E, Slatinskaya O, Ponomareva N, Parshina E, et al.
Anal Chem
. 2024 Oct;
96(43):17432-17443.
PMID: 39402710
Extracellular vesicles (EVs), biomimetics, and other biological nanoparticles (BNs) produced from human cells are gaining increasing attention in the fields of molecular diagnostics and nanomedicine for the delivery of therapeutic...
7.
Kalendar R, Ivanov K, Akhmetollayev I, Kairov U, Samuilova O, Burster T, et al.
Anal Chem
. 2024 Sep;
96(39):15526-15530.
PMID: 39288265
The success of DNA analytical methods, including long-read sequencing, depends on the availability of high-quality, purified DNA. Previously, we developed a method and device for isolating high-molecular-weight (HMW) DNA for...
8.
Zdravkova K, Mijanovic O, Brankovic A, Ilicheva P, Jakovleva A, Karanovic J, et al.
Cells
. 2024 Jun;
13(11.
PMID: 38891048
Cysteine cathepsins F and W are members of the papain-like cysteine protease family, which have distinct structural features and functional roles in various physiological and pathological processes. This review provides...
9.
Kutumova E, Akberdin I, Egorova V, Kolesova E, Parodi A, Pokrovsky V, et al.
Heliyon
. 2024 May;
10(10):e30962.
PMID: 38803942
The application of nanomedicine in the treatment of acute lung injury (ALI) has great potential for the development of new therapeutic strategies. To gain insight into the kinetics of nanocarrier...
10.
Ponomareva N, Brezgin S, Karandashov I, Kostyusheva A, Demina P, Slatinskaya O, et al.
Pharmaceutics
. 2024 May;
16(5).
PMID: 38794330
Biological nanoparticles (NPs), such as extracellular vesicles (EVs), exosome-mimetic nanovesicles (EMNVs) and nanoghosts (NGs), are perspective non-viral delivery vehicles for all types of therapeutic cargo. Biological NPs are renowned for...